Edition:
United Kingdom

Kitov Pharma Ltd (KTOV.OQ)

KTOV.OQ on NASDAQ Stock Exchange Capital Market

1.46USD
19 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.46
Open
$1.47
Day's High
$1.47
Day's Low
$1.28
Volume
28,419
Avg. Vol
17,781
52-wk High
$3.81
52-wk Low
$1.28

Latest Key Developments (Source: Significant Developments)

Kitov pharmaceuticals announces receipt of FDA's favorable response to NT219's pre-ind meeting package
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Kitov Pharmaceuticals Holdings Ltd :Kitov Pharmaceuticals announces receipt of FDA's favorable response to NT219's pre-ind meeting package.Kitov Pharmaceuticals - U.S. ‍FDA agreed to proposed Chemistry Manufacturing, Controls (CMC), preclinical, clinical development plans for NT219​.Kitov Pharmaceuticals Holdings Ltd - U.S. ‍FDA further agreed that one-month animal toxicology studies for NT219 would be sufficient to support ind​.Kitov Pharmaceuticals Holdings Ltd - U.S. ‍FDA further agreed that no toxicology studies of NT219 together with Gemcitabine would be necessary​.Kitov Pharmaceuticals Holdings Ltd - ‍expect to submit ind with FDA for NT219​ during first half of 2019.  Full Article

Kitov Pharmaceuticals announces phase III/IV clinical trial for KIT-302 successfully meets primary endpoint
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Kitov Pharmaceuticals Holdings Ltd :Kitov pharmaceuticals announces phase iii/iv clinical trial for kit-302 successfully meets primary endpoint, and also demonstrates drug candidate improves renal function.Kitov pharmaceuticals holdings - ‍study demonstrated that treatment with kit-302 led to a statistically significant reduction of serum creatinine​.Kitov pharmaceuticals- ‍randomized double-blind, placebo-controlled renal function clinical trial for kit-302, met primary efficacy endpoint​.Kitov pharmaceuticals holdings ltd - ‍anticipates completion and submission of kit-302​ report to fda by january 2018.Kitov pharmaceuticals - ‍data from trial demonstrated kit-302 lowered systolic blood pressure a comparable amount to widely used antihypertension drug​.  Full Article

Kitov Pharmaceuticals files for mixed shelf of up to $200 mln
Monday, 12 Dec 2016 

Kitov Pharmaceuticals Holdings Ltd :Kitov pharmaceuticals holdings ltd - files for mixed shelf of up to $200 million - sec filing.  Full Article